Phlexglobal's eTMF Quality and Innovation Seminar, France
Phlexglobal has announced that it will be hosting the eTMF Quality and Innovation Seminar at the Hilton Paris Opera venue in France. (Source: Pharmaceutical Technology)
Source: Pharmaceutical Technology - September 26, 2017 Category: Pharmaceuticals Source Type: news

Prudential Cleanroom Services Announces Open House Preview of Laundry Processing Facility
Prudential Cleanroom Services has announced a date for an open house preview of its cleanroom laundry processing facility in Nashua, New Hampshire. (Source: Pharmaceutical Technology)
Source: Pharmaceutical Technology - September 26, 2017 Category: Pharmaceuticals Source Type: news

Modality Solutions to Present at Annual Temperature Controlled Life Science Supply Chains Forum
Modality Solutions has announced that it will be sponsoring and presenting at the 15th Annual Global Forum - Temperature Controlled Life Science Supply Chains. (Source: Pharmaceutical Technology)
Source: Pharmaceutical Technology - September 26, 2017 Category: Pharmaceuticals Source Type: news

Novartis and The Max Foundation to provide cancer access programme in lower-income countries
Novartis has entered a new collaboration with The Max Foundation to support continued access to treatment free of charge for almost 34,000 patients suffering from chronic myeloid leukaemia (CML), gastrointestinal tumours (GIST) and other rare cancers … (Source: Pharmaceutical Technology)
Source: Pharmaceutical Technology - September 25, 2017 Category: Pharmaceuticals Source Type: news

Allergan receives FDA ’s RTF letter for Vraylar sNDA to treat schizophrenia
Allergan ’s supplemental new drug application (sNDA) for Vraylar (cariprazine) to treat negative symptoms associated with schizophrenia in adult patients has received a Refusal to File (RTF) letter from the US Food and Drug Administration (FDA). (Source: Pharmaceutical Technology)
Source: Pharmaceutical Technology - September 25, 2017 Category: Pharmaceuticals Source Type: news

CFDA approves Gilead ’s Sovaldi for chronic hepatitis C treatment
The China Food and Drug Administration (CFDA) has approved Gilead Sciences ’ Sovaldi (sofosbuvir at 400mg) for the treatment of patients with chronic hepatitis C virus (HCV) infection. (Source: Pharmaceutical Technology)
Source: Pharmaceutical Technology - September 25, 2017 Category: Pharmaceuticals Source Type: news

Mithra and Libbs partner to commercialise Estelle oral contraceptive in Brazil
Belgium-based Mithra has signed a binding Head of Terms agreement with biopharmaceutical company Libbs for an exclusive licence to commercialise its new combined oral contraceptive (COC) product, Estelle, in Brazil. (Source: Pharmaceutical Technology)
Source: Pharmaceutical Technology - September 25, 2017 Category: Pharmaceuticals Source Type: news

Pharmabide Pharmaceutical Services-Clinical Research and Development Services and Pharmaceutical Market Licensing
Pharmabide Pharmaceutical Services is a consultancy firm for clinical trials, regulatory affairs, and pharmacovigilance. (Source: Pharmaceutical Technology)
Source: Pharmaceutical Technology - September 25, 2017 Category: Pharmaceuticals Source Type: news

Zenith Technologies Named 'Great Place to Work 2017'
In February this year, Zenith Technologies was officially recognised as a great place to work at the 'Great Place to Work Best Workplaces in Ireland' awards in Dublin. (Source: Pharmaceutical Technology)
Source: Pharmaceutical Technology - September 25, 2017 Category: Pharmaceuticals Source Type: news

IKA Listed Within TOP 100 SMEs in Germany
IKA has announced that is has been ranked among the most innovative small and medium-sized enterprises (SME) in Germany. (Source: Pharmaceutical Technology)
Source: Pharmaceutical Technology - September 25, 2017 Category: Pharmaceuticals Source Type: news

Hard nut to crack: new trial brings new hope for children with peanut allergies
Aimmune Therapeutics has just started a new European trial to treat peanut allergy in children. Elly Earls finds out what it will involve and why it ’s been such a long time coming. (Source: Pharmaceutical Technology)
Source: Pharmaceutical Technology - September 24, 2017 Category: Pharmaceuticals Source Type: news

European Commission approves Roche ’s tocilizumab to treat giant cell arteritis
Roche ’s Actemra / RoActemra (tocilizumab) has received approval from the European Commission (EC) to treat giant cell arteritis (GCA). (Source: Pharmaceutical Technology)
Source: Pharmaceutical Technology - September 24, 2017 Category: Pharmaceuticals Source Type: news

Merck ’s Keytruda receives accelerated FDA approval for GEJ adenocarcinoma
Merck ’s Keytruda (pembrolizumab) has received approval from the US Food and Drug Administration (FDA) to treat patients with recurrent locally advanced or metastatic gastric or gastroesophageal junction (GEJ) adenocarcinoma. (Source: Pharmaceutical Technology)
Source: Pharmaceutical Technology - September 24, 2017 Category: Pharmaceuticals Source Type: news

Gerresheimer Group-Pharmaceutical Plastic and Glass Packaging
Gerresheimer is a leading global partner to the pharma and healthcare industry. With specialty glass and plastic products, Gerresheimer contributes to health and well-being. The company has worldwide operations and 11,000 employees manufacture the pr … (Source: Pharmaceutical Technology)
Source: Pharmaceutical Technology - September 24, 2017 Category: Pharmaceuticals Source Type: news

OncoQR ’s S-TIR vaccine technology helps induce killing of cancer cells
Austrian start-up OncoQR ML has confirmed that a single therapeutic vaccine based on its Specific Total Immune Remodeler (S-TIR) platform is capable of simultaneously inducing and activating the killing of tumour target expressing cells. (Source: Pharmaceutical Technology)
Source: Pharmaceutical Technology - September 24, 2017 Category: Pharmaceuticals Source Type: news